The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · cited 1×
“In addition, IDH1 and IDH2 mutations, which are found in ~90 % of secondary GBM, are also rare in pediatric tumors [31, 33, 46, 54].”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631 · cited 1×
“1 genes (HIST1H3B and HIST1H3C) are frequent in pediatric GBM (approximately 40 % of tumors) but rare in adults [1, 7, 14, 22, 27, 41, 46, 48, 52, 53].”
BackgroundSelf-citationSturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
Self-citationSt. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345 · cited 1×
“1 genes (HIST1H3B and HIST1H3C) are frequent in pediatric GBM (approximately 40 % of tumors) but rare in adults [1, 7, 14, 22, 27, 41, 46, 48, 52, 53].”
Backgroundthe St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
Schindler, G., Capper, D., Meyer, J., Janzarik, W., Omran, H., Herold-Mende, C., Schmieder, K., Wesseling, P., Mawrin, C., Hasselblatt, M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0802-6 · Cited by 1,034
Self-citationKhuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028 · cited 1×
“1 genes (HIST1H3B and HIST1H3C) are frequent in pediatric GBM (approximately 40 % of tumors) but rare in adults [1, 7, 14, 22, 27, 41, 46, 48, 52, 53].”
BackgroundSelf-citationEANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Weller, M., van den Bent, M., Hopkins, K., Tonn, J. C., Stupp, R., Falini, A., Cohen-Jonathan-Moyal, E., Frappaz, D., Henriksson, R., Balana, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70011-7 · Cited by 750
Self-citationPaugh, B. S., Qu, C., Jones, C., Liu, Z., Adamowicz-Brice, M., Zhang, J., Bax, D. A., Coyle, B., Barrow, J., Hargrave, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7252 · Cited by 654
Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., et al. (2014) · Nature Genetics · doi:10.1038/ng.2936 · Cited by 647
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Sturm, D., Bender, S., Jones, D. T. W., Lichter, P., Grill, J., Becher, O., Hawkins, C., Majewski, J., Jones, C., Costello, J. F., et al. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3655 · Cited by 555 · cited 1×
“Although childhood and adult GBM share a related histopathological appearance and comparable clinical outcomes, it is now becoming apparent that these tumors are molecularly distinct entities with differing genomic and epigenomic landscapes [5, 15, 20, 21, 33, 45, 46].”
BackgroundSelf-citationThe integrated landscape of driver genomic alterations in glioblastoma
Frattini, V., Trifonov, V., Chan, J. M., Castano, A., Lia, M., Abate, F., Keir, S. T., Ji, A. X., Zoppoli, P., Niola, F., et al. (2013) · Nature Genetics · doi:10.1038/ng.2734 · Cited by 524
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Taylor, K. R., Mackay, A., Truffaux, N., Butterfield, Y. S., Morozova, O., Philippe, C., Castel, D., Grasso, C. S., Vinci, M., Carvalho, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2925 · Cited by 517
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Fontebasso, A. M., Papillon-Cavanagh, S., Schwartzentruber, J., Nikbakht, H., Gerges, N., Fiset, P.-O., Bechet, D., Faury, D., De Jay, N., Ramkissoon, L. A., et al. (2014) · Nature Genetics · doi:10.1038/ng.2950 · Cited by 465
Self-citationCohen, K. J., Pollack, I. F., Zhou, T., Buxton, A., Holmes, E. J., Burger, P. C., Brat, D. J., Rosenblum, M. K., Hamilton, R. L., Lavey, R. S., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq191 · Cited by 399
Bady, P., Sciuscio, D., Diserens, A.-C., Bloch, J., van den Bent, M. J., Marosi, C., Dietrich, P.-Y., Weller, M., Mariani, L., Heppner, F. L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1016-2 · Cited by 344
Paugh, B. S., Broniscer, A., Qu, C., Miller, C. P., Zhang, J., Tatevossian, R. G., Olson, J. M., Geyer, J. R., Chi, S. N., da Silva, N. S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5677 · Cited by 320
Bandopadhayay, P., Bergthold, G., London, W. B., Goumnerova, L. C., Morales La Madrid, A., Marcus, K. J., Guo, D., Ullrich, N. J., Robison, N. J., Chi, S. N., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24958 · Cited by 313
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Jones, C., & Baker, S. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3811 · Cited by 298
Hovestadt, V., Remke, M., Kool, M., Pietsch, T., Northcott, P. A., Fischer, R., Cavalli, F. M. G., Ramaswamy, V., Zapatka, M., Reifenberger, G., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1126-5 · Cited by 292
Self-citationMistry, M., Zhukova, N., Merico, D., Rakopoulos, P., Krishnatry, R., Shago, M., Stavropoulos, J., Alon, N., Pole, J. D., Ray, P. N., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3922 · Cited by 288
Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
Kleinschmidt-DeMasters, B. K., Aisner, D. L., Birks, D. K., & Foreman, N. K. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31827f9c5e · Cited by 260
Schiffman, J. D., Hodgson, J. G., VandenBerg, S. R., Flaherty, P., Polley, M.-Y. C., Yu, M., Fisher, P. G., Rowitch, D. H., Ford, J. M., Berger, M. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1851 · Cited by 251
Pleomorphic Xanthoastrocytoma: Natural History and Long‐Term Follow‐Up
Ida, C. M., Rodriguez, F. J., Burger, P. C., Caron, A. A., Jenkins, S. M., Spears, G. M., Aranguren, D. L., Lachance, D. H., & Giannini, C. (2015) · Brain Pathology · doi:10.1111/bpa.12217 · Cited by 246
Paediatric and adult malignant glioma: close relatives or distant cousins?
Jones, C., Perryman, L., & Hargrave, D. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.87 · Cited by 243
Puget, S., Philippe, C., Bax, D. A., Job, B., Varlet, P., Junier, M.-P., Andreiuolo, F., Carvalho, D., Reis, R., Guerrini-Rousseau, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030313 · Cited by 242
Faury, D., Nantel, A., Dunn, S. E., Guiot, M.-C., Haque, T., Hauser, P., Garami, M., Bognár, L., Hanzély, Z., Liberski, P. P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8626 · Cited by 225
Self-citationStokland, T., Liu, J.-F., Ironside, J. W., Ellison, D. W., Taylor, R., Robinson, K. J., Picton, S. V., & Walker, D. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq092 · Cited by 206
Duffner, P. K., Horowitz, M. E., Krischer, J. P., Burger, P. C., Cohen, M. E., Sanford, R. A., Friedman, H. S., & Kun, L. E. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.2.152 · Cited by 201
H3F3A K27M mutations in thalamic gliomas from young adult patients
Aihara, K., Mukasa, A., Gotoh, K., Saito, K., Nagae, G., Tsuji, S., Tatsuno, K., Yamamoto, S., Takayanagi, S., Narita, Y., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not144 · Cited by 199
Donson, A. M., Addo‐Yobo, S. O., Handler, M. H., Gore, L., & Foreman, N. K. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20803 · Cited by 196
Molecular neuro-oncology in clinical practice: a new horizon
Weller, M., Pfister, S. M., Wick, W., Hegi, M. E., Reifenberger, G., & Stupp, R. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70168-2 · Cited by 189
Self-citationRobinson, G. W., Orr, B. A., & Gajjar, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-258 · Cited by 184
A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas
Bax, D. A., Mackay, A. G., Little, S. E., Carvalho, D. M., Viana‐Pereira, M., Tamber, N., Grigoriadis, A. E., Ashworth, A., Reis, R. M., Ellison, D. W., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0438 · Cited by 160
Pollack, I. F., Finkelstein, S. D., Burnham, J. A., Holmes, E. J., Hamilton, R. L., Yates, A. J., Finlay, J. L., & Sposto, R. (2001) · PubMed · Cited by 138
Qu, H., Jacob, K., Fattet, S., Ge, B., Barnett, D., Delattre, O., Faury, D., Montpetit, A., Solomon, L. A., Hauser, P., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop001 · Cited by 119
Self-citationWeber, R. G., Hoischen, A., Ehrler, M., Zipper, P., Kaulich, K., Blaschke, B., Becker, A. J., Weber‐Mangal, S., Jauch, A. T., Radlwimmer, B., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209851 · Cited by 118
Self-citationBroniscer, A., Tatevossian, R., Sabin, N. D., Klimo, P. D., Dalton, J., Lee, R. P., Gajjar, A. J., & Ellison, D. W. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12093 · Cited by 114
Pediatric glioblastomas: A histopathological and molecular genetic study
Suri, V. S., Das, P., Jain, A., Sharma, M. C., Borkar, S. A., Suri, A., Gupta, D. K., & Sarkar, C. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-092 · Cited by 110
Phillips, J. J., Aranda, D., Ellison, D. W., Judkins, A. R., Croul, S. E., Brat, D. J., Ligon, K. L., Horbinski, C., Venneti, S., Zadeh, G. M., et al. (2013) · Brain Pathology · doi:10.1111/bpa.12043 · Cited by 108
Self-citationKoelsche, C., Sahm, F., Wöehrer, A., Jeibmann, A., Schittenhelm, J., Kohlhof, P., Preusser, M., Romeike, B. F. M., Dohmen‐Scheufler, H., Hartmann, C. J., et al. (2013) · Brain Pathology · doi:10.1111/bpa.12111 · Cited by 85
Self-citationCeppa, E. P., Bouffet, É., Griebel, R., Robinson, C. A., & Tihan, T. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9216-z · Cited by 77
Gene Expression Profiling from Formalin-Fixed Paraffin-Embedded Tumors of Pediatric Glioblastoma
Haque, T., Faury, D., Albrecht, S., López‐Aguilar, E., Hauser, P., Garami, M., Hanzély, Z., Bognár, L., Maestro, R. F. D., Atkinson, J. D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0525 · Cited by 76
Self-citationMGMT gene promoter methylation in pediatric glioblastomas
Srivastava, A., Jain, A., Jha, P., Suri, V. S., Sharma, M. C., Mallick, S., Puri, T., Gupta, D. K., Gupta, A., & Sarkar, C. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1214-y · Cited by 41
MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA
Lee, J. Y., Park, C., Park, S., Wang, K., Cho, B. K., & Kim, S. (2011) · Child s Nervous System · doi:10.1007/s00381-011-1525-7 · Cited by 32
Buttarelli, F. R., Massimino, M., Antonelli, M., Lauriola, L., Nozza, P., Donofrio, V., Arcella, A., Oliva, M. A., Rocco, C. D., & Giangaspero, F. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1191-1 · Cited by 32
Cited by
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Self-citationMackay, A., Burford, A., Carvalho, D., Izquierdo, E., Fazal-Salom, J., Taylor, K. R., Bjerke, L., Clarke, M., Vinci, M., Nandhabalan, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.017 · Cited by 1,212
Self-citationWHO 2016 Classification of gliomas
Wesseling, P., & Capper, D. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12432 · Cited by 795
Self-citationGlioblastoma: pathology, molecular mechanisms and markers
Aldape, K., Zadeh, G., Mansouri, S., Reifenberger, G., & von Deimling, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1432-1 · Cited by 735
Self-citationAdvances in the molecular genetics of gliomas — implications for classification and therapy
Reifenberger, G., Wirsching, H.-G., Knobbe-Thomsen, C. B., & Weller, M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.204 · Cited by 662
Self-citation
Metadata
- Authors
- Korshunov, A., Ryzhova, M., Hovestadt, V., Bender, S., Sturm, D., Capper, D., Meyer, J., Schrimpf, D., Kool, M., Northcott, P. A., Zheludkova, O., Milde, T., Witt, O., Kulozik, A. E., Reifenberger, G., Jabado, N., Perry, A., Lichter, P., von Deimling, A., Pfister, S. M., & Jones, D. T. W.
- Venue
- Acta Neuropathologica
- Published
- 2015-03-10
- Volume
- 129
- Issue
- 5
- Pages
- 669-678
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1970654034
- Cited by
- 350
- References
- 53
- FWCI
- 21.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.